CINC

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Mineralys Therapeutics

The company develops an aldosterone synthase inhibitor medicine to treat patients with uncontrolled or treatment-resistant hypertension and chronic kidney disease.

Mineralys

This biopharmaceutical company develops aldosterone synthase inhibitors to treat patients with uncontrolled hypertension and related cardio-renal-metabolic diseases.

CVRx

This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Cinclus Pharma

This biopharmaceutical company develops small molecule drugs for patients suffering from gastric acid-related diseases, including erosive gastroesophageal reflux disease.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.

Cerenis Therapeutics Holding SA

This biopharmaceutical company develops high-density lipoprotein therapies to treat patients with cardiovascular and metabolic diseases, as well as renal and oncology conditions.